TrialPloS one2016

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.

Richard N Greenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.